Poland· PL-100476625

emoliumLEK

A carbamid, urea, kombinationen product containing ureum + glycerolum, registered in Poland by Karo Healthcare AB. The same ATC class is registered in 4 of our 19 countries.

ATC D02AE51

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedemoliumLEKATCD02AE51REGISTER NO.PL-100476625PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Carbamid, urea, kombinationen is registered in 4 of 19 countries.

Countries holding a registration under ATC D02AE51 (carbamid, urea, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Carbamid, urea, kombinationen · ATC D02AE51

4 / 19 countries

  • Finlandprice
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Ureum + Glycerolum
Manufacturer
Karo Healthcare AB
Country
Poland (PL)
ATC code
D02AE51
ATC class
Carbamid, Urea, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05907734714270
  • gtin
    05907734714263

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carbamid, urea, kombinationen in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbamid, urea, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Norway · Canoderm Comp, Canomini
  • Sweden · Karbamid/Glycerol Aco, Miniderm Comp

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8d5f6736-27f2-4da5-8c1d-78eb8d4880ec
GET /v1/drugs/8d5f6736-27f2-4da5-8c1d-78eb8d4880ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Krem",
  "source": "urpl",
  "strength": "(20 mg + 200 mg)/g",
  "packaging": "05907734714270 ¦ OTC ¦ 151689\n1 tuba 100 g\n05907734714263 ¦ OTC ¦ 151690\n1 poj. 500 g",
  "substance": "Ureum 20 mg/g + Glycerolum 200 mg/g",
  "common_name": "Ureum + Glycerolum",
  "pl_product_id": "100476625",
  "pozwolenie_nr": "27910",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about carbamid, urea, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.